{
    "2020-06-29": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Gains",
                        "Lags Market"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Race for a COVID-19 vaccine has drug makers scaling up manufacturing â€” before one is developed",
                "features": {
                    "keywords": [
                        "COVID-19",
                        "vaccine",
                        "drug makers",
                        "manufacturing"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "J&J (JNJ) Discontinues Phase III Study of Stelara for Lupus",
                "features": {
                    "keywords": [
                        "J&J",
                        "Discontinues",
                        "Phase III",
                        "Stelara",
                        "Lupus"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}